Clinical trials are fragile. Supply chain disruptions like cold chain failures or single-source dependencies threaten patient safety and trial success.
- U.S. Pharma Tariffs And MFN Become Law After April 2 Update
- 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
- From Policy To Practice: Embedding Export Compliance In Clinical Supply
- What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design
- AI And Digital Tools Advance Clinical Trial Supply Chains
- Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials
- How The Strait Of Hormuz Crisis Is Stalling U.S. Medical Breakthroughs
ON-DEMAND WEBINARS
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1078167682-brexit-uk-ireland-eu]( "Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain")
Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply ChainWith many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.
-
![7 Seven Tips GettyImages-1450702003]( "7 Key Considerations For Designing The Optimal IRT/RTSM")
7 Key Considerations For Designing The Optimal IRT/RTSMSponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
![GettyImages-487610898 Vendors]( "Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your Trial")
Mid-Study RTSM Migration: How To Switch Vendors Without Disrupting Your TrialEvaluate the risks of staying with an underperforming RTSM provider versus the benefits of a mid-study transition. Modern migration tools now offer a secure path to protect trial data and timelines.
-
![GettyImages-1070902452-planning-tracking-packaging-shipment]( "Winning The Race To FPI With Early Randomization And Trial Supply Management")
Winning The Race To FPI With Early Randomization And Trial Supply ManagementLearn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
![iStock-1224887299-box-logistics-package]( "The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective")
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply PerspectivePerhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
![Risk Management-GettyImages-665231256]( "Flexible Integrations To Reduce Risks And Increase Efficiencies")
Flexible Integrations To Reduce Risks And Increase EfficienciesLearn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![iStock-1276580570-cryopreservation]( "Key Considerations For Labeling Your Cell Or Gene Therapy")
Key Considerations For Labeling Your Cell Or Gene TherapyAs sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
![GettyImages-893884852 doctors tablet data]( "Study, Not Software: Aligning RTSM To The Protocol")
Study, Not Software: Aligning RTSM To The ProtocolHow can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
![GettyImages-1445871463 supply chain]( "A Guide To RTSM For Clinical Trials")
A Guide To RTSM For Clinical TrialsLooking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
